Integra LifeSciences Holdings

Healthcare · Medical Devices

16.10$ +1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Integra LifeSciences Holdings (IART) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 3,602 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IART
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	49	38	35	66	87	228	275	413	457	448	614	818	1,034	940	1,017	1,144	1,164	1,196	1,579	1,775	1,808	3,211	3,108	3,303	3,615	3,782	3,890	3,782	4,037	3,602
Current Assets	40	32	27	43	46	108	152	188	216	266	222	340	497	365	445	452	453	525	529	438	495	822	775	858	1,237	1,154	1,161	1,058	1,082	1,160
Cash	12	2.1	5.3	19	14	45	44	79	70	47	23	57	184	72	129	101	97	121	72	48	102	175	139	199	470	513	457	276	246	235
Cash & Short-Term Investments	12	2.1	5.3	24	15	67	99	109	101	127	23	57	184	72	129	101	97	121	72	48	102	175	139	199	470	513	457	309	274	264
Receivables	2.9	2.8	3.1	8.4	13	14	19	29	47	49	85	104	112	103	106	118	115	118	132	132	148	252	266	275	226	243	263	259	272	279
Inventory	2.6	2.4	2.7	10	17	25	29	41	56	67	94	145	146	140	147	171	172	213	237	211	217	296	280	316	310	317	325	390	429	493
Property, Plant & Equipment	–	–	–	–	12	12	17	20	25	27	43	62	70	84	99	131	178	200	210	205	222	269	300	337	288	312	311	–	–	–
Goodwill	–	–	–	–	–	32	22	27	39	68	162	207	212	262	262	293	294	250	364	512	511	938	926	954	932	1,013	1,039	1,055	1,097	615
Intangible Assets	–	–	1.4	13	25	32	45	79	99	133	180	196	226	211	195	237	212	197	459	604	561	1,160	1,079	1,032	989	1,146	1,127	1,068	1,208	1,135
Total Liabilities	2.3	2.6	3.3	28	33	24	27	144	149	159	317	558	684	495	517	651	646	526	874	1,023	968	2,249	1,732	1,887	2,100	2,098	2,085	2,194	2,492	2,559
Current Liabilities	2.2	2.4	3.0	15	21	19	22	21	24	31	274	192	175	157	200	102	107	119	126	139	124	349	263	331	401	340	321	307	922	456
Short-Term Debt	–	–	–	2.3	8.9	3.6	9.4	–	–	–	220	120	100	77	108	–	–	1.7	3.8	14	665	60	23	70	159	75	67	30	622	141
Accounts Payable	0.1	0.5	0.6	1.0	3.4	2.9	3.8	7.9	10	9.0	20	23	23	25	28	28	37	51	34	35	29	94	76	113	55	62	102	92	83	96
Long-Term Debt	–	–	–	–	4.8	–	–	119	119	118	0.5	330	490	309	295	532	520	392	626	701	665	1,781	1,211	1,199	1,408	1,389	1,300	1,485	1,196	1,730
Shareholders' Equity	46	36	31	38	54	204	248	269	308	290	296	260	350	445	500	493	518	670	704	751	840	962	1,376	1,417	1,515	1,685	1,804	1,588	1,545	1,043
Retained Earnings	-59	-76	-88	-94	-106	-80	-44	-17	-0.3	37	66	98	132	167	233	261	302	285	315	146	220	285	348	399	532	699	879	947	940	423
Shares Outstanding	28	30	32	34	35	56	62	66	62	69	65	59	57	59	60	59	57	58	66	74	79	79	84	86	85	85	84	80	77	77

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings